Latest Cardiologynews Podcast Episodes
Top stories from the American Heart Association scientific sessions
MDedge Cardiocast - December 27, 2019 09:00 - 7 minutes ★★★★★ - 16 ratingsISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics Further analyses from the DAPA-HF trial showed dapagliflozin cu...
Vascepa gains event-reduction nod; diabetes ups ischemic risks
MDedge Cardiocast - December 20, 2019 09:00 - 8 minutes ★★★★★ - 16 ratingsVascepa approved for cardiovascular risk reduction The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial. ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding Novel oral anticoagulants may be preferred over warfarin i...
Post-STEMI events less likely in women; bariatric surgery may lower stroke risk
MDedge Cardiocast - December 13, 2019 09:00 - 7 minutes ★★★★★ - 16 ratingsWomen have fewer cardiovascular events after non–ST-segment elevation ACS But they also remain undertreated with guideline-directed therapies. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * ...
New trick for old drug; Vascepa cost effective for CV reduction
MDedge Cardiocast - December 06, 2019 09:00 - 7 minutes ★★★★★ - 16 ratingsIcosapent ethyl cost effective in REDUCE-IT analysis Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcast...
Card Talk: TAVR and glass ceilings
MDedge Cardiocast - November 29, 2019 09:00 - 43 minutes ★★★★★ - 16 ratingsThis week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory Healthcare, Kendra J. Grubb, MD, and Isida Byku, MD. Both followed a unique track, training i...
ISCHEMIA trial, DAPA-HF, and valsartan recall: AHA Special
MDedge Cardiocast - November 26, 2019 09:00 - 32 minutes ★★★★★ - 16 ratingsIn this special meeting edition of the Cardiocast, MDedge Cardiology editor Catherine Hackett is joined by MDedge reporters Mitchel L. Zoler, Bruce Jancin, and Richard Mark Kirkner. The MDedge cardiology team reviews three big stories from the 2019 annual scientific sessions of the American H...
Long-awaited ISCHEMIA results to change practice, DAPA-HF elevates dapagliflozin for HFrEF
MDedge Cardiocast - November 22, 2019 09:00 - 8 minutes ★★★★★ - 16 ratingsISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurvey...
Pot heightens stroke, arrhythmia risks; keeping low LDL and BP slashes lifetime heart risk
MDedge Cardiocast - November 15, 2019 09:00 - 8 minutes ★★★★★ - 16 ratingsGetting high heightens stroke, arrhythmia risks Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct20...
How risk factors in childhood translate to CV outcomes in adulthood
MDedge Cardiocast - November 08, 2019 09:00 - 8 minutes ★★★★★ - 16 ratingsClosing the missing link between childhood risk factors and adult cardiovascular outcomes Prescient childhood cohort studies launched in the 1970s are paying off. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOc...
Driving while defibrillating; hypertension holds greater risk in black patients
MDedge Cardiocast - November 01, 2019 08:00 - 7 minutes ★★★★★ - 16 ratingsPatients frequently drive too soon after ICD implantation Many patients didn’t recall ever receiving instruction about when to drive again. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * One-thi...
AFib hits Native Americans hard; TAVR shown durable, safe after 5 years
MDedge Cardiocast - October 25, 2019 08:00 - 7 minutes ★★★★★ - 16 ratingsStrong showing for TAVR after 5 years in PARTNER 2A Transcatheter and surgical aortic valve replacement had similar rates of death or disabling stroke. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * ...
Practice changing prevention data from ESC 2019 Part II
MDedge Cardiocast - October 22, 2019 09:00 - 42 minutes ★★★★★ - 16 ratingsMDedge reporters discuss the latest in practice-changing data from the 2019 annual congress of the European Society of Cardiology in Paris. Join Mitchel L. Zoler, Bruce Jancin, Kari Oakes, and MDedge Cardiology editor Catherine Hackett as they discuss what they reported from the annual meeting.
Statins tied to skin, soft tissue infections; new Card Talk episode
MDedge Cardiocast - October 18, 2019 08:00 - 41 minutes ★★★★★ - 16 ratingsStatin use linked to risk of skin and soft tissue infections Use of statins was associated with increased risk of SSTIs at an average of 91, 182, and 365 days. Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS Patients who took rivaroxaban experienced alm...
Troponin protocol rapidly rules out MI; hidden risk of moderate aortic stenosis
MDedge Cardiocast - October 11, 2019 08:00 - 8 minutes ★★★★★ - 16 ratingsNovel cardiac troponin protocol rapidly rules out MI Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission. Study questions preemptive TEVAR for extended type A dissections Interim results from a single-c...
Sun sets on longer DAPT after PCI; inactivity boosts post-MI risk
MDedge Cardiocast - October 04, 2019 08:00 - 8 minutes ★★★★★ - 16 ratingsSmoking and inactivity are the most powerful lifestyle risk factors after an MI Insufficient activity beats out obesity or above-target LDL cholesterol. Ticagrelor monotherapy tops DAPT for high-risk PCI patients TWILIGHT findings support move to shorter dual-antiplatelet therapy. Pan...
Cardiology dead last as women’s IM subspecialty choice
MDedge Cardiocast - September 27, 2019 08:00 - 7 minutes ★★★★★ - 16 ratingsCardiology dead last as women’s IM subspecialty choice Women in internal medicine residencies were more likely than men to report that they had never considered cardiology as a career choice. Beta-blockers effective, safe for HFrEF with renal dysfunction Their role is solidified for esse...
An antiplatelet surprise; Europeans go low in cholesterol guidelines
MDedge Cardiocast - September 20, 2019 08:00 - 9 minutes ★★★★★ - 16 ratingsPrasugrel bests ticagrelor in ACS in surprise findings ISAR-REACT 5 was the first-ever direct head-to-head look at two potent P2Y12 inhibitors in this setting. European cholesterol guidelines push LDL targets below 55 mg/dL PCSK-9 inhibitors are elevated to a top-tier recommendation in v...
SGLT-2 inhibitors and more practice changing data from ESC 2019
MDedge Cardiocast - September 16, 2019 14:00 - 22 minutes ★★★★★ - 16 ratingsMDedge reporters discuss the latest in practice-changing data from the 2019 annual congress of the European Society of Cardiology in Paris. Join Mitchel L. Zoler, Bruce Jancin, Kari Oakes, and MDedge Cardiology editor Catherine Hackett as they discuss what they reported from the annual meetin...
Overweight BMI surpasses 'normal' and introducing the 'Card Talk' segment
MDedge Cardiocast - September 13, 2019 08:00 - 40 minutes ★★★★★ - 16 ratingsWe introduce a brand new format with Jerome Dwyer, MD, brother of our host, Jim Dwyer, MD, for a new segment that we're calling 'Card Talk' where Dr. Jim and Dr. Jerry talk about the current clinical state of cardiology and take a peek into the future. This week in cardiology news: Surviva...
Dapagliflozin transforms into heart failure drug
MDedge Cardiocast - September 06, 2019 08:00 - 9 minutes ★★★★★ - 16 ratingsDAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug Proof that dapagliflozin significantly helped heart failure patients without diabetes recategorizes the drug as a major agent for treating heart failure. New hypertension cases halved with community-wide...
CV cost of smoking lasts a quarter century
MDedge Cardiocast - August 30, 2019 08:00 - 7 minutes ★★★★★ - 16 ratingsThis week in cardiology: PCSK9 inhibition cuts events in very-high-risk groups ODYSSEY OUTCOMES analyses peg prior CABG and polyvascular disease as targets for alirocumab. Cardiovascular cost of smoking may last up to 25 years Past smokers face an elevated cardiovascular risk for up to 25...
Two FDA approvals, smoking impacts CV health for 25 years
MDedge Cardiocast - August 23, 2019 08:00 - 8 minutes ★★★★★ - 16 ratingsTAVR valves now FDA approved for low-risk patients The FDA's decision will expand TAVR access to younger, healthier patients. FDA approves baroreflex activation for advanced HF A phase 4 trial will investigate impact on hospitalizations and mortality. Top line results: Dapagliflozin m...
NSAIDS mediate CV risk and hypertension linked to dementia
MDedge Cardiocast - August 16, 2019 08:00 - 8 minutes ★★★★★ - 16 ratingsThe top news in cardiology: Midlife hypertension linked to dementia risk Elevated blood pressure in midlife is associated with risk of subsequent dementia, but whether the risk is treatable is unclear. Ambulatory BP slightly better than in-office measures for predicting cardiovascular o...
AI for AFib and acupuncture for angina
MDedge Cardiocast - August 09, 2019 08:00 - 9 minutes ★★★★★ - 16 ratingsThe top stories in cardiology: Artificial intelligence technology meets AFib detection An AI-enabled ECG model suggests clinical implications for early identification of atrial fibrillation. Older patients who stop statins may be increasing their cardiovascular risk Discontinuation of sta...
Seven simple rules of heart failure risk - you only need two
MDedge Cardiocast - August 02, 2019 08:00 - 7 minutes ★★★★★ - 16 ratingsThe top news in cardiology: Meeting just 2 of 7 ‘simple’ goals lowers HF risk American Heart Association recommendations seem to lower risk even if only a couple of the 'Simple 7' are mastered. Increased cardiovascular risk seen early on with testosterone replacement therapy Testosterone r...
Air pollution correlated with cardio mortality; statins crush early seizure risk
MDedge Cardiocast - July 26, 2019 08:00 - 8 minutes ★★★★★ - 16 ratingsStatins crush early seizure risk poststroke Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study. Atherosclerotic disease risk persists after smoking cessation Clinicians should reinforce smoking cessation with awa...
Half of sudden cardiac deaths linked to silent MI; Uncontrolled hypertension and dementia
MDedge Cardiocast - July 19, 2019 08:00 - 9 minutes ★★★★★ - 16 ratingsThis week in cardiology: Systolic, diastolic BP each tied to adverse CV outcomes Diastolic hypertension can't be ignored, though systolic ultimately has a larger impact. Almost half of sudden cardiac deaths linked to prior silent MI Prior silent MIs were detected in nearly half of sudden...
Omega-3s cut heart failure; Fat-but-fit theory takes a hit
MDedge Cardiocast - July 12, 2019 08:00 - 8 minutes ★★★★★ - 16 ratingsThe top stories in cardiology: New findings cast more doubt on fat-but-fit theory Patients who are obese and metabolically healthy face higher cardiac risk Higher omega-3 fatty acid levels cut heart failure risk A large multi-ethnic cohort study shows significantly higher levels of EPA in...
Lipoprotein(a) levels and genes boost ischemic stroke risk
MDedge Cardiocast - July 05, 2019 08:00 - 8 minutes ★★★★★ - 16 ratingsThis week's top stories in cardiology: Lipoprotein(a) levels, genes boost ischemic stroke risk Could some elderly skip statins based on negative risk markers? Cardiac events jump after COPD exacerbation CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma...
Continue using paclitaxel-eluting PAD devices
MDedge Cardiocast - June 28, 2019 00:04 - 7 minutes ★★★★★ - 16 ratingsThis week's top stories in cardiology: FDA Panel: Continue using paclitaxel-eluting PAD Devices, with caveats. Although the benefits of the devices were clear, the panel felt there should be a label change to warn of the late mortality signal seen in a key meta-analysis. Many cardiac cat...
Related Cardiologynews Topics